Prothena Corp. PLC Co-Founder, President and CEO Dale Schenk, a protein immunotherapy pioneer, died on Sept. 30 from pancreatic cancer that he revealed publicly less than two years ago.
Schenk’s death closely followed Prothena’s Sept. 26 announcement that its CEO would take a medical leave of absence to focus...




![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
